Statement of Changes in Beneficial Ownership (4)
February 14 2020 - 4:38PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Bacher Dror |
2. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp.
[
DRIO
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Operating Officer |
|
(Last)
(First)
(Middle)
8 HATOKHEN STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/12/2020 |
|
(Street)
CAESAREA INDUSTRIAL PARK, L3 3088900
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Common Stock | 2/12/2020 | | A | | 45000 | A | $0 | 77284 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Stock Option (right to buy) | $7.736 | 2/12/2020 | | A | | 28664 | | (1) | 2/12/2026 | Common Stock | 28664 | $0 | 28664 | D | |
| Explanation of Responses: |
| (1) | The options will vest in twelve equal quarterly installments over a three year period commencing on February 10, 2020, subject to the Director's continued employment by the company. The option will not be subject to section 6(i) (Termination for Continuous Services) of the Plan and will be exercisable until its expiration date on the sixth anniversary from its grant date |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Bacher Dror
8 HATOKHEN STREET
CAESAREA INDUSTRIAL PARK, L3 3088900 |
|
| Chief Operating Officer |
|
Signatures
|
| /s/ Dror Bacher | | 2/14/2020 |
| **Signature of Reporting Person | Date |
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Apr 2023 to Apr 2024
